Fidelity Investments’s MaxCyte MXCT Stock Holding History
Bought
Maintained
Sold
Other funds holding MXCT
Fidelity Investments's MXCT Position: Q3 2026 in Review
Fidelity Investments reduced its MaxCyte (MXCT) stake by 2.9% in Q3 2026, selling an estimated $6.5K and leaving 175,037 shares worth $196K. The position accounts for ﹤0.01% of the portfolio, ranked #3705.
Fidelity Investments first reported a position in MXCT in Q1 2022 and has held it in 19 quarters since. The position peaked at $14.4M in Q1 2024. 120 funds tracked by Wall St. Rank hold MXCT as of Q3 2026.
- Fidelity Investments held 175,037 shares of MaxCyte worth $196K as of Q3 2026.
- Fidelity Investments sold 5,301 MaxCyte shares in Q3 2026, an estimated $6.5K.
- MaxCyte made up ﹤0.01% of Fidelity Investments's portfolio in Q3 2026, its #3705 holding.
- Fidelity Investments first reported a position in MaxCyte in Q1 2022 and has held it in 19 quarters since.
- Fidelity Investments's MaxCyte position peaked at $14.4M in Q1 2024.
- 120 funds tracked by Wall St. Rank held MaxCyte as of Q3 2026.
Based on Fidelity Investments's 13F filing for Q3 2026, filed 10 Nov 2026.